Authors: VANDERMEIJDEN A BRAUSI M ZAMBON V KIRKELS W HOLTL W BONO A DEBALINCOURT C SYLVESTER R

Citation: A. Vandermeijden et al., EORTC PROTOCOL-30911 - PHASE-III STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG TICE AND BCG TICE PLUS ISONIAZID IN INTERMEDIATE ANDHIGH-RISK PTA-PTL PAPILLARY CARCINOMA OF THE BLADDER, The Journal of urology, 159(5), 1998, pp. 554-554

Authors: VANDERMEIJDEN A BRAUSI M HOLTL W MACK D VANVELTHOVEN R DASILVA FC SYLVESTER R DEBALINCOURT C

Citation: A. Vandermeijden et al., COMPARATIVE-STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG, ORBCG-RISK PTA-PT1 PAPILLARY CARCINOMA OF THE URINARY-BLADDER - FIRST RESULTS OF EORTC-30911(INH IN INTERMEDIATE AND HIGH), European journal of cancer, 33, 1997, pp. 615-615

Authors: VEGT PDJ VANDERMEIJDEN APM SYLVESTER R BRAUSI M HOLTL W DEBALINCOURT C

Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911, The Journal of urology, 157(4), 1997, pp. 1246-1249

Authors: VEGT PDJ VANDERMEIJDEN APM SYLVESTER R BRAUSI M HOLTL W DEBALINCOURT C

Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911 - REPLY, The Journal of urology, 157(4), 1997, pp. 1249-1249

Authors: TOULAS C MIHURA J DEBALINCOURT C MARQUES B MAREK E SOULA G ROCHE H FABRE G

Citation: C. Toulas et al., POTENTIAL PROGNOSTIC VALUE IN HUMAN BREAST-CANCER OF CYTOSOLIC NME1 PROTEIN-DETECTION USING AN ORIGINAL HEN SPECIFIC ANTIBODY, British Journal of Cancer, 73(5), 1996, pp. 630-635